Magnesium-dependent enzyme active site

Magnesium-dependent enzyme active sites are specialized catalytic regions within proteins that require magnesium ions (Mg2+) as essential cofactors to facilitate chemical reactions. These ions play a fundamental role in stabilizing negatively charged substrates or transition states, particularly those involving phosphate groups in ATP, DNA, or RNA (Source: Wikipedia, Magnesium in biology). This structural motif is ubiquitous, appearing in over 300 different enzymes including kinases, polymerases, and integrases, making it vital for processes like DNA replication, signal transduction, and energy metabolism (Source: NIH, Magnesium). In medicine, these sites are therapeutic targets for several classes of drugs, most notably HIV integrase strand transfer inhibitors (INSTIs) and fluoroquinolone antibiotics, which utilize a chelating mechanism to bind the metal ions and halt enzymatic activity (Source: PubMed, PMID: 21114321). However, because magnesium-binding motifs are so common in the human body, designing drugs that specifically target a single magnesium-dependent enzyme without affecting others remains a significant challenge in drug discovery (Source: Nature Reviews Drug Discovery, doi:10.1038/nrd.2017.236). As a target definition, this term is considered too broad as it encompasses thousands of unrelated proteins across diverse biological pathways.

Other names

Mg2+-dependent catalytic siteMagnesium-binding pocketMetalloenzyme active site (Magnesium)Magnesium-dependent catalytic motif

Drugs typically act as chelators that coordinate with the magnesium ions within the active site, thereby displacing necessary water molecules or substrates and inhibiting the enzyme's catalytic activity.